Vaxcyte (PCVX) Treasury Shares (2020 - 2026)

Vaxcyte (PCVX) has 6 years of Treasury Shares data on file, last reported at $3.3 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $3.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (changed N/A YoY), and the FY2025 annual result was $175513.0, down 85.86% from the prior year.
• Treasury Shares advanced to $3.3 million in Q1 2026 per PCVX's latest filing, from $175513.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $3.3 million in Q1 2026 and troughed at $175513.0 in Q2 2024.
• A 5-year average of $1.1 million and a median of $763561.0 in 2023 frame the typical range for Treasury Shares.
• On a YoY basis, Treasury Shares climbed as much as 1087.38% in 2025 and fell as far as 85.86% in 2025.
• A 5-year view of Treasury Shares shows it stood at $456766.0 in 2022, then soared by 64.96% to $753462.0 in 2023, then jumped by 64.74% to $1.2 million in 2024, then slumped by 85.86% to $175513.0 in 2025, then soared by 1797.26% to $3.3 million in 2026.
• Business Quant data shows PCVX's Treasury Shares at $3.3 million in Q1 2026, $175513.0 in Q4 2025, and $2.4 million in Q3 2025.